Cited 7 time in
Two subtypes of cutaneous melanoma with distinct mutational signatures and clinico-genomic characteristics
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Yoon-Seob | - |
| dc.contributor.author | Lee, Minho | - |
| dc.contributor.author | Chung, Yeun-Jun | - |
| dc.date.accessioned | 2023-04-27T09:40:37Z | - |
| dc.date.available | 2023-04-27T09:40:37Z | - |
| dc.date.issued | 2022-09-29 | - |
| dc.identifier.issn | 1664-8021 | - |
| dc.identifier.issn | 1664-8021 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/2516 | - |
| dc.description.abstract | Background: To decipher mutational signatures and their associations with biological implications in cutaneous melanomas (CMs), including those with a low ultraviolet (UV) signature. Materials and Methods: We applied non-negative matrix factorization (NMF) and unsupervised clustering to the 96-class mutational context of The Cancer Genome Atlas (TCGA) cohort (N = 466) as well as other publicly available datasets (N = 527). To explore the feasibility of mutational signature-based classification using panel sequencing data, independent panel sequencing data were analyzed. Results: NMF decomposition of the TCGA cohort and other publicly available datasets consistently found two mutational signatures: UV (SBS7a/7b dominant) and non-UV (SBS1/5 dominant) signatures. Based on mutational signatures, TCGA CMs were classified into two clusters: UV-high and UV-low. CMs belonging to the UV-low cluster showed significantly worse overall survival and landmark survival at 1-year than those in the UV-high cluster; low or high UV signature remained the most significant prognostic factor in multivariate analysis. The UV-low cluster showed distinct genomic and functional characteristic patterns: low mutation counts, increased proportion of triple wild-type and KIT mutations, high burden of copy number alteration, expression of genes related to keratinocyte differentiation, and low activation of tumor immunity. We verified that UV-high and UV-low clusters can be distinguished by panel sequencing. Conclusion: Our study revealed two mutational signatures of CMs that divide CMs into two clusters with distinct clinico-genomic characteristics. Our results will be helpful for the clinical application of mutational signature-based classification of CMs. | - |
| dc.format.extent | 13 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Frontiers Media S.A. | - |
| dc.title | Two subtypes of cutaneous melanoma with distinct mutational signatures and clinico-genomic characteristics | - |
| dc.type | Article | - |
| dc.publisher.location | 스위스 | - |
| dc.identifier.doi | 10.3389/fgene.2022.987205 | - |
| dc.identifier.scopusid | 2-s2.0-85140027443 | - |
| dc.identifier.wosid | 000868618300001 | - |
| dc.identifier.bibliographicCitation | Frontiers in Genetics, v.13, pp 1 - 13 | - |
| dc.citation.title | Frontiers in Genetics | - |
| dc.citation.volume | 13 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 13 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Genetics & Heredity | - |
| dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
| dc.subject.keywordPlus | ASSOCIATION | - |
| dc.subject.keywordAuthor | cutaneous melanoma | - |
| dc.subject.keywordAuthor | mutational signature | - |
| dc.subject.keywordAuthor | next generation seqencing | - |
| dc.subject.keywordAuthor | ultraviolet | - |
| dc.subject.keywordAuthor | melanoma | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
